California Public Employees Retirement System Portfolio holdings
The California Public Employees’ Retirement System (CalPERS), established in 1932 and headquartered in Sacramento, California, is the largest public pension fund in the U.S., managing over $510 billion in assets as of late 2024 to provide retirement and health benefits to more than 2 million state and local government employees, retirees, and their families. Operating as a defined benefit plan, CalPERS invests globally across equities, fixed income, real estate, private equity, and infrastructure, guided by a 13-member board and a commitment to sustainable investing and ESG (environmental, social, governance) principles under Chief Investment Officer Ben Meng since 2024. Known for its influential shareholder activism—pushing for corporate governance reforms—CalPERS serves over 3,000 employers, including state agencies and school districts, balancing long-term funding needs with a $100 billion unfunded liability challenge. As a cornerstone of California’s public sector, it blends financial stewardship with a mission to secure retiree livelihoods.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$475M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$463M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$408M |
| 4 |
Adobe
ADBE
|
+$333M |
| 5 |
T-Mobile US
TMUS
|
+$205M |
Top Sells
| 1 |
Apple
AAPL
|
+$372M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$146M |
| 3 |
Sysco
SYY
|
+$144M |
| 4 |
AGN
Allergan plc
AGN
|
+$134M |
| 5 |
Welltower
WELL
|
+$124M |
Sector Composition
| 1 | Technology | 20.98% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 12.83% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Consumer Staples | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LDL
2651
DELISTED
Lydall, Inc.
LDL
| $526K | ﹤0.01% |
38,790
-200
| -0.5% | -$2.71K |
|
2652
Nature's Sunshine
NATR
$301M
| $523K | ﹤0.01% |
58,080
| – | – |
|
2653
Willdan Group
WLDN
$1.55B
| $523K | ﹤0.01% |
20,900
+400
| +2% | +$10K |
|
|
AMAG
2654
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $523K | ﹤0.01% |
68,372
-228
| -0.3% | -$1.74K |
|
|
AKTS
2655
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $521K | ﹤0.01% |
62,800
+44,900
| +251% | +$372K |
|
|
RADA
2656
DELISTED
Rada Electronic Industries Ltd
RADA
| $521K | ﹤0.01% |
79,736
+51,486
| +182% | +$336K |
|
2657
Hyliion Holdings
HYLN
$286M
| $520K | ﹤0.01% |
18,940
+2,140
| +13% | +$58.8K |
|
2658
Village Super Market
VLGEA
$580M
| $520K | ﹤0.01% |
18,746
+3,200
| +21% | +$88.8K |
|
2659
Capital Southwest
CSWC
$1.28B
| $519K | ﹤0.01% |
38,500
+14,800
| +62% | +$200K |
|
|
MNK
2660
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $519K | ﹤0.01% |
193,805
+11,605
| +6% | +$31.1K |
|
2661
RBB Bancorp
RBB
$338M
| $517K | ﹤0.01% |
37,869
+17,790
| +89% | +$243K |
|
|
SCU
2662
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $517K | ﹤0.01% |
39,946
+2,500
| +7% | +$32.4K |
|
2663
WM Technology
MAPS
$135M
| $516K | ﹤0.01% |
+51,100
| New | +$516K |
|
2664
Personalis
PSNL
$541M
| $514K | ﹤0.01% |
+39,600
| New | +$514K |
|
2665
eGain
EGAN
$219M
| $513K | ﹤0.01% |
46,199
+7,799
| +20% | +$86.6K |
|
|
PNNT
2666
Pennant Park Investment Corp
PNNT
$464M
| $513K | ﹤0.01% |
146,200
+45,900
| +46% | +$161K |
|
|
MSB
2667
Mesabi Trust
MSB
$419M
| $510K | ﹤0.01% |
29,121
-3,200
| -10% | -$56K |
|
|
ISEE
2668
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $510K | ﹤0.01% |
99,903
+41,103
| +70% | +$210K |
|
|
EMWP
2669
DELISTED
Eros Media World PLC
EMWP
| $510K | ﹤0.01% |
8,075
+4,785
| +145% | +$302K |
|
2670
AMC Entertainment Holdings
AMC
$1.44B
| $509K | ﹤0.01% |
11,868
+453
| +4% | +$19.4K |
|
2671
Alpha and Omega Semiconductor
AOSL
$875M
| $508K | ﹤0.01% |
46,675
+1,301
| +3% | +$14.2K |
|
2672
Blue Bird Corp
BLBD
$1.85B
| $508K | ﹤0.01% |
33,896
+2,084
| +7% | +$31.2K |
|
2673
Global Partners
GLP
$1.75B
| $508K | ﹤0.01% |
51,878
-1,949
| -4% | -$19.1K |
|
|
AVID
2674
DELISTED
Avid Technology Inc
AVID
| $507K | ﹤0.01% |
69,771
+6,815
| +11% | +$49.5K |
|
|
TCRR
2675
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $507K | ﹤0.01% |
+33,000
| New | +$507K |
|